{"URL": "https://www.wired.com/1999/09/tech-stocks-make-dow-happy", "heading": "tech stocks make dow happy", "subheading": "last week's losses are just a fading memory as the us dollar shows signs of life.", "author": "reuters", "category": "business", "type": "article", "timestamp": "09.17.1999 02:20 PM", "text": "new york - us stocks closed higher on friday with technology stocks leading the recovery from the week's losses as the dollar showed signs of life against the yen and fears of an interest-rate hike retreated. based on early and unofficial data, the dow jones industrial average was up 66.17 points, or 0.62 percent, at 10,803.63the nasdaq composite index was up 62.92 points, or 2.24 percent, at 2,869.64.the session showed little of the choppy weakness from recent sessions, despite the so-called \"triple witching\" expiration of options and futures.\"today is an interlude,\" said gregory nie, technical analyst at everen securities.analysts said the triple witching, which was seen as a contributing factor behind much of the latest selling pressure in the market, had a leveling-out impact.\"this is mostly related to triple-witching expirations leaning in the buy side,\" peter coolidge, senior equity trader at brean murray & co. said of the market's early gains.the 30-year us treasury bond was up 3/4 of a point, pushing its yield down to 6.05 percent from 6.08 percent at thursday's close.financial stocks were among the dow's positive components, american express co. was up 3-5/16 at 139-13/16 and j.p. morgan & co. inc. was up 15/16 at 122-15/16.positive earnings news from graphics publishing software company adobe systems inc. (adbe) also lifted the market. adobe shares surged 7-1/8 to 105 after the company said on thursday its third-quarter earnings topped analysts' forecasts and it would split its stock two for one. the stock was upgraded by several analysts friday.among other active stocks, internet e-commerce company vitria technology led the nasdaq percentage gainer list and was up about 200 percent from its initial public offering of 16. the stock closed at 48-1/4, up 32-1/4.shares in biotechnology firm liposome co. slid 8-3/8 to 8-7/16 after the us food and drug administration rejected the company's breast cancer drug evacet.copyright"}